Long-term clinical outcomes of endoscopic submucosal dissection in rectal neuroendocrine tumors based on resection margin status: a real-world study

[1]  Minhu Chen,et al.  Development of a novel scoring system based on endoscopic appearance for management of rectal neuroendocrine tumors , 2020, Endoscopy.

[2]  T. Matsuda,et al.  Predicting and managing complications following colonoscopy: risk factors and management of advanced interventional endoscopy with a focus on colorectal ESD , 2020, Expert review of medical devices.

[3]  T. Shichinohe,et al.  Metachronous liver metastases after long-term follow-up of endoscopic resection for rectal neuroendocrine neoplasms: a report of three cases , 2020, Surgical Case Reports.

[4]  P. Ruszniewski,et al.  Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors. , 2019, Best practice & research. Clinical endocrinology & metabolism.

[5]  R. Bleday,et al.  Local Excision Versus Radical Resection for 1- to 2-cm Neuroendocrine Tumors of the Rectum: A National Cancer Database Analysis , 2019, Diseases of the colon and rectum.

[6]  Y. Hirooka,et al.  Preoperative endoscopic predictors of severe submucosal fibrosis in colorectal tumors undergoing endoscopic submucosal dissection , 2019, Endoscopy International Open.

[7]  J. Strosberg,et al.  Gastroenteropancreatic Neuroendocrine Tumors , 2018, CA: a cancer journal for clinicians.

[8]  A. Sundin,et al.  Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need , 2018, Neuroendocrinology.

[9]  J. Berlin,et al.  NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[10]  J. Ramage,et al.  Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme , 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[11]  M. Hara,et al.  Perforation and Postoperative Bleeding Associated with Endoscopic Submucosal Dissection in Colorectal Tumors: An Analysis of 398 Lesions Treated in Saga, Japan , 2018, Internal medicine.

[12]  T. Myklebust,et al.  Survival in neuroendocrine neoplasms; A report from a large Norwegian population‐based study , 2018, International journal of cancer.

[13]  Wei-feng Chen,et al.  Efficacy and safety of endoscopic submucosal dissection for submucosal tumors of the colon and rectum. , 2017, Gastrointestinal endoscopy.

[14]  M. Kudo,et al.  Risk Factors for Postoperative Bleeding in Endoscopic Submucosal Dissection of Colorectal Tumors , 2017, Oncology.

[15]  Shouhao Zhou,et al.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States , 2017, JAMA oncology.

[16]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[17]  Eun Soo Kim,et al.  Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study , 2016, The American Journal of Gastroenterology.

[18]  D. Chang,et al.  Prediction model and risk score for perforation in patients undergoing colorectal endoscopic submucosal dissection. , 2016, Gastrointestinal endoscopy.

[19]  Y. McConnell.  Surgical management of rectal carcinoids: trends and outcomes from the Surveillance, Epidemiology, and End Results database (1988 to 2012). , 2016, American journal of surgery.

[20]  Wei-feng Chen,et al.  Efficacy and Safety of Endoscopic Submucosal Dissection for Colorectal Carcinoids. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  P. Ruszniewski,et al.  ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms , 2016, Neuroendocrinology.

[22]  J. Ramage,et al.  Review article: the investigation and management of rectal neuroendocrine tumours , 2014, Alimentary pharmacology & therapeutics.

[23]  A. Grossman,et al.  Changes in the Epidemiology of Neuroendocrine Tumours , 2015, Neuroendocrinology.

[24]  H. Qiu,et al.  Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors. , 2015, World journal of gastroenterology.

[25]  Y. Ohe,et al.  Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion , 2015, Journal of Gastroenterology.

[26]  L. M. Wong Kee Song,et al.  Endoscopically identified well-differentiated rectal carcinoid tumors: impact of tumor size on the natural history and outcomes. , 2014, Gastrointestinal endoscopy.

[27]  T. Matsuda,et al.  Colorectal ESD: current indications and latest technical advances. , 2014, Gastrointestinal endoscopy clinics of North America.

[28]  N. Yahagi,et al.  Long-Term Outcome of Patients with Locally Resected High- and Low-Risk Rectal Carcinoid Tumors , 2014, Journal of Gastrointestinal Surgery.

[29]  J. S. Kim,et al.  Which endoscopic treatment is the best for small rectal carcinoid tumors? , 2013, World journal of gastrointestinal endoscopy.

[30]  D. Metz,et al.  Consensus guidelines for the management and treatment of neuroendocrine tumors. , 2013, Pancreas.

[31]  H. Sung,et al.  Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution , 2012, European journal of gastroenterology & hepatology.

[32]  T. Stahl,et al.  Transanal endoscopic microsurgery for rectal carcinoids: the largest reported United States experience , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[33]  D. Chang,et al.  Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread. , 2011, Endoscopy.

[34]  M. Mori,et al.  Endoscopic Treatment of Rectal Carcinoid Tumors , 2010, Diseases of the colon and rectum.

[35]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[36]  I. Modlin,et al.  A 5‐decade analysis of 13,715 carcinoid tumors , 2003, Cancer.